Thromb Haemost 1993; 69(01): 087
DOI: 10.1055/s-0038-1651555
Letter to the Editor
Schattauer GmbH Stuttgart

A Note on the Calculation of Recovery for Factor VIII Infusions

Martin L Lee
Baxter Healthcare Corporation, Hyland Division, 550 N. Brand Boulevard Glendale, California 91203, U.S.A.
,
Edward D Gomperts
Baxter Healthcare Corporation, Hyland Division, 550 N. Brand Boulevard Glendale, California 91203, U.S.A.
,
Henry S Kingdon
Baxter Healthcare Corporation, Hyland Division, 550 N. Brand Boulevard Glendale, California 91203, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 07 April 1992

Accepted after revision 05 August 1992

Publication Date:
04 July 2018 (online)

 
  • References

  • 1 Morfini M, Lee M, Messori A. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Thromb Haemostas 1991; 66: 384-386
  • 2 Allain JP, Verroust F, Soulier JP. In vitro and in vivo characterization of factor VIII preparations. Vox Sanguinis 1980; 38: 68-80
  • 3 Hellstern P, Kiehl R, Miyashita C, Schwerdt H, von Blohn G, Köhler M, Büttner M, Wenzel E. Factor VIII: C (FVIII: C) recovery and halflife after infusion of steam-treated high purity factor VIII concentrate in severe hemophilia – comparison of one-stage assay, two-stage assay and a chromogenic substrate assay. Thromb Haemostas 1986; 56: 353-359
  • 4 Brettler DB, Forsberg AD, Levine PH, Petillo J, Lamon K, Sullivan JL. Factor VIII: C concentrate purified from plasma using monoclonal antibodies: human studies. Blood 1989; 73: 1859-1863
  • 5 Lee ML, White G, Morfini M, Courter S, Kingdon H. Comparison of recombinant and monoclonally-purified AHF pharmacokinetics: The use of a two-phase linear regression model. Blood 1989; 74 (Suppl. 01) 393a
  • 6 Shanbrom E, Thelin GM. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate. JAMA 1969; 208: 1853-1856
  • 7 Abildgaard CF, Simone JV, Corrigan JJ. et al. Treatment of hemophilia with glycine-precipitated factor VIII. N Engl J Med 1966; 275: 471-475